References
- Chen D, Jiang X, Liu J, Jin X, Zhang C, Ping Q. 2010. In vivo evaluation of novel pH-sensitive mPEG-Hz-Chol conjugate in liposomes: pharmacokinetics, tissue distribution, efficacy assessment. Artif Cells Blood Substit Immobil Biotechnol. 38: 136–142.
- Chen D, Lian S, Sun J, Liu Z, Zhao F, Jiang Y, et al. 2014. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition. Drug Deliv. 3:1–6.
- Chen D, Liu W, Shen Y, Mu H, Zhang Y, Ping Q. 2011. Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon. Int J Nanomedicine. 6:2053–2061.
- Chen D, Mu H, Sun K, Liu W. 2012a. Synthesis, anticoagulant activity and potential drug carrier of biomimetic N-Cholesteryl hemisuccinate-O-sulfate chitosan polymer of blood cell membrane. J Control Release.172:e25.
- Chen D, Sun K, Mu H, Tang M, Liang R, Wang A, et al. 2012b. pH and temperature dual-sensitive liposome gel based on novel cleavable mPEG-Hz-CHEMS polymeric vaginal delivery system. Int J Nanomedicine. 7:2621–2630.
- Chen D, Wang H. 2014. Novel pH-sensitive biodegradable polymeric drug delivery systems based on ketal polymers. J Nanosci Nanotechnol. 14:983–989.
- Choi KY, Min KH, Yoon HY, Kim K, Park JH, Kwon IC, et al. 2011. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials. 32:1880–1889.
- Coradini D, Zorzet S, Rossin R, Scarlata I, Pellizzaro C, Turrin C, et al. 2004. Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But. Clin Cancer Res. 10:4822–4830.
- Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic G. 2007. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA. 104:11298–11303.
- Götte M, Yip GW. 2006. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res. 66:10233–10237.
- Jaracz S, Chen J, Kuznetsova LV, Ojima I. 2005. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem. 13:5043–5054.
- Lee H, Mok H, Lee S, Oh YK, Park TG. 2007. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release. 119:245–252.
- Morra M. 2005. Engineering of biomaterials surfaces by hyaluronan. Biomacromolecules. 6:1205–1223.
- Peer D, Margalit R. 2004. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int J Cancer. 108:780–789.
- Sleeman J, Rudy W, Hofmann M, Moll J, Herrlich P, Ponta H. 1996. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol. 135:1139–1150.
- Stern R, Asari AA, Sugahara KN. 2006. Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 85:699–715
- Toole BP. 2004. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 4:528–539.
- Yang C, Cao M, Liu H, He Y, Xu J, Du Y, et al. 2012. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem. 287:43094–430107.
- Yu H, Mu H, Xiu L, Sun K, Liu W, Chen D. 2013. A Novel Ketal-Based Chitosan as Nano-Vehicles for Potential pH-Sensitive Nanomedicine Delivery. Nanosci Nanotechnol Lett. 5:1007–1011.